Yubo International Biotech Limited's ability to collect accounts receivable sequentially worsen to 0.09, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Yubo International Biotech Limited's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 4056 days, from 3650 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector Yubo International Biotech Limited achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Yubo International Biotech Limited Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MAGAA Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	16.99 %	-8.5 %	-16.33 %	-47.58 %	-43.96 %
Y / Y Revenue Change	-	-	-	-	-
Receivable Turnover Ratio (TTM)	0.09	0.1	0.1	-	-
MAGAA's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	3875	3727	3819	-	-
Seq. Receivable Change	2.86 %	-2.77 %	20.79 %	-3.15 %	-19.55 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

MAGAA Company Profile • Back to MAGAA Efficiency Comparisons • Compare MAGAA Receivables Turnover Ratio to its Competitors

Financial Statements
Yubo International Biotech Limited's Accounts Receivable	$ 0 Millions	Visit MAGAA's Balance sheet
Yubo International Biotech Limited's Sales TTM	$ 0 Millions	Visit MAGAA's Income Statement
Sources of MAGAA's Revenues		Visit MAGAA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MAGAA's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MAGAA's Growth Rates	MAGAA's Roa	MAGAA's Inventory Turnover Ratio	MAGAA's Dividend Comparisons
MAGAA's Profitability Ratios	MAGAA's Roi	MAGAA's Asset Turnover Ratio	MAGAA's Dividend Growth
MAGAA's Valuation Ratios	MAGAA's Roe	MAGAA's Financial Strength Ratios	MAGAA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
IMPACT BIOMEDICAL INC.	0.09	$ 0.035 Millions	$ 0.398 Millions

Date modified: 2026-08-15T07:30:26+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.